FN2 Earnings Intelligence
STERIS plc ratios
STERIS plc (STE) Ratios (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2025 | 3/31/2026 | 3/31/2027 est. | 3/31/2028 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $348.3 | $208.4 | $207 | $171.7 | $439.6 | - | - |
| + Debt | $3,088.4 | $3,078.7 | $3,206.1 | $2,043.7 | $1,931.7 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $4,585.1 | $4,957.8 | $5,138.7 | $5,459.5 | $5,935.9 | $6,361.6 | $6,765.1 |
| % Growth | 47.5% | 8.1% | 3.6% | 6.2% | 8.7% | 7.2% | 6.3% |
| Gross Profit | $2,016.4 | $2,159.7 | $2,218.2 | $2,402.8 | $2,626.5 | - | - |
| % Margin | 44.0% | 43.6% | 43.2% | 44.0% | 44.2% | - | - |
| EBITDA | $978.7 | $821.1 | $1,401.4 | $1,342.9 | $1,588.3 | - | - |
| % Margin | 21.3% | 16.6% | 27.3% | 24.6% | 26.8% | - | - |
| Net Income | $243.9 | $107 | $378.2 | $614.6 | $782.3 | - | - |
| % Margin | 5.3% | 2.2% | 7.4% | 11.3% | 13.2% | - | - |
| Diluted EPS | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 | $11.16 | $12.18 |
| % Growth | -46.4% | -56.9% | 256.1% | 62.7% | 27.9% | 40.7% | 9.2% |
| Operating Cash Flow | $684.8 | $756.9 | $973.3 | $1,148.1 | $1,341.4 | - | - |
| CapEx | $287.6 | $362 | $360.3 | $370.1 | $369 | - | - |
| Free Cash Flow | $397.2 | $395 | $612.9 | $778 | $972.4 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2025 | 3/31/2026 | 3/31/2027 est. | 3/31/2028 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $4,585.1 | $4,957.8 | $5,138.7 | $5,459.5 | $5,935.9 | $6,361.6 | $6,765.1 |
| Gross Profit | $2,016.4 | $2,159.7 | $2,218.2 | $2,402.8 | $2,626.5 | - | - |
| EBITDA | $978.7 | $821.1 | $1,401.4 | $1,342.9 | $1,588.3 | - | - |
| Net Income | $243.9 | $107 | $378.2 | $614.6 | $782.3 | - | - |
| Diluted EPS | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 | $11.16 | $12.18 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $348.3 | $208.4 | $207 | $171.7 | $439.6 |
| Short-term Debt | $142.9 | $60 | $85.9 | $125 | $118.9 |
| Long-term Debt | $2,945.5 | $3,018.7 | $3,120.2 | $1,918.7 | $1,812.8 |
| Total Debt | $3,088.4 | $3,078.7 | $3,206.1 | $2,043.7 | $1,931.7 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $684.8 | $756.9 | $973.3 | $1,148.1 | $1,341.4 |
| Capital Expenditure | $287.6 | $362 | $360.3 | $370.1 | $369 |
| Free Cash Flow | $397.2 | $395 | $612.9 | $778 | $972.4 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | 47.5% | 8.1% | 3.6% | 6.2% | 8.7% |
| Gross Margin | 44.0% | 43.6% | 43.2% | 44.0% | 44.2% |
| EBITDA Margin | 21.3% | 16.6% | 27.3% | 24.6% | 26.8% |
| Net Margin | 5.3% | 2.2% | 7.4% | 11.3% | 13.2% |
| FCF Margin | 8.7% | 8.0% | 11.9% | 14.3% | 16.4% |
| Diluted EPS Growth | -46.4% | -56.9% | 256.1% | 62.7% | 27.9% |